Novavax’s Adjuvant Licensing Strategy Continues With Pfizer Pact

 
• By Joseph Haas
  
Novavax inks potentially lucrative long-term license deal with Pfizer (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business